Neurogene Inc. NGNE
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2014-03-07
Neurogene Inc. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Cvijic Christine Mikail | President and CFO | 2026-05-06 | Sell | 4,800 | $30.07 |
| Cvijic Christine Mikail | President and CFO | 2026-05-06 | Sell | 4,800 | $32.44 |
| Cvijic Christine Mikail | President and CFO | 2026-03-26 | Sell | 2,558 | $21.62 |
| McMinn Rachel | Chief Executive Officer | 2026-03-26 | Sell | 3,352 | $22.07 |
| Jordan Julie | Chief Medical Officer | 2026-03-26 | Sell | 828 | $21.89 |
| Cobb Stuart | Chief Scientific Officer | 2026-03-13 | Sell | 3,991 | $20.41 |
| Cobb Stuart | Chief Scientific Officer | 2026-03-13 | Sell | 2,658 | $21.34 |
| Cobb Stuart | Chief Scientific Officer | 2026-03-13 | Sell | 148 | $22.08 |
Source: SEC EDGAR filings · CIK 0001404644 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.